Cargando…
Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response
BACKGROUND: Differently from HIV-1, HIV-2 disease progression usually takes decades without antiretroviral therapy and the majority of HIV-2 infected individuals survive as elite controllers with normal CD4(+) T cell counts and low or undetectable plasma viral load. Neutralizing antibodies (Nabs) ar...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016255/ https://www.ncbi.nlm.nih.gov/pubmed/24156513 http://dx.doi.org/10.1186/1742-4690-10-110 |
_version_ | 1782315477170651136 |
---|---|
author | Rocha, Cheila Calado, Rita Borrego, Pedro Marcelino, José Maria Bártolo, Inês Rosado, Lino Cavaco-Silva, Patrícia Gomes, Perpétua Família, Carlos Quintas, Alexandre Skar, Helena Leitner, Thomas Barroso, Helena Taveira, Nuno |
author_facet | Rocha, Cheila Calado, Rita Borrego, Pedro Marcelino, José Maria Bártolo, Inês Rosado, Lino Cavaco-Silva, Patrícia Gomes, Perpétua Família, Carlos Quintas, Alexandre Skar, Helena Leitner, Thomas Barroso, Helena Taveira, Nuno |
author_sort | Rocha, Cheila |
collection | PubMed |
description | BACKGROUND: Differently from HIV-1, HIV-2 disease progression usually takes decades without antiretroviral therapy and the majority of HIV-2 infected individuals survive as elite controllers with normal CD4(+) T cell counts and low or undetectable plasma viral load. Neutralizing antibodies (Nabs) are thought to play a central role in HIV-2 evolution and pathogenesis. However, the dynamic of the Nab response and resulting HIV-2 escape during acute infection and their impact in HIV-2 evolution and disease progression remain largely unknown. Our objective was to characterize the Nab response and the molecular and phenotypic evolution of HIV-2 in association with Nab escape in the first years of infection in two children infected at birth. RESULTS: CD4(+) T cells decreased from about 50% to below 30% in both children in the first five years of infection and the infecting R5 viruses were replaced by X4 viruses within the same period. With antiretroviral therapy, viral load in child 1 decreased to undetectable levels and CD4(+) T cells recovered to normal levels, which have been sustained at least until the age of 12. In contrast, viral load increased in child 2 and she progressed to AIDS and death at age 9. Beginning in the first year of life, child 1 raised high titers of antibodies that neutralized primary R5 isolates more effectively than X4 isolates, both autologous and heterologous. Child 2 raised a weak X4-specific Nab response that decreased sharply as disease progressed. Rate of evolution, nucleotide and amino acid diversity, and positive selection, were significantly higher in the envelope of child 1 compared to child 2. Rates of R5-to-X4 tropism switch, of V1 and V3 sequence diversification, and of convergence of V3 to a β-hairpin structure were related with rate of escape from the neutralizing antibodies. CONCLUSION: Our data suggests that the molecular and phenotypic evolution of the human immunodeficiency virus type 2 envelope are related with the dynamics of the neutralizing antibody response providing further support for a model in which Nabs play an important role in HIV-2 pathogenesis. |
format | Online Article Text |
id | pubmed-4016255 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40162552014-05-11 Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response Rocha, Cheila Calado, Rita Borrego, Pedro Marcelino, José Maria Bártolo, Inês Rosado, Lino Cavaco-Silva, Patrícia Gomes, Perpétua Família, Carlos Quintas, Alexandre Skar, Helena Leitner, Thomas Barroso, Helena Taveira, Nuno Retrovirology Research BACKGROUND: Differently from HIV-1, HIV-2 disease progression usually takes decades without antiretroviral therapy and the majority of HIV-2 infected individuals survive as elite controllers with normal CD4(+) T cell counts and low or undetectable plasma viral load. Neutralizing antibodies (Nabs) are thought to play a central role in HIV-2 evolution and pathogenesis. However, the dynamic of the Nab response and resulting HIV-2 escape during acute infection and their impact in HIV-2 evolution and disease progression remain largely unknown. Our objective was to characterize the Nab response and the molecular and phenotypic evolution of HIV-2 in association with Nab escape in the first years of infection in two children infected at birth. RESULTS: CD4(+) T cells decreased from about 50% to below 30% in both children in the first five years of infection and the infecting R5 viruses were replaced by X4 viruses within the same period. With antiretroviral therapy, viral load in child 1 decreased to undetectable levels and CD4(+) T cells recovered to normal levels, which have been sustained at least until the age of 12. In contrast, viral load increased in child 2 and she progressed to AIDS and death at age 9. Beginning in the first year of life, child 1 raised high titers of antibodies that neutralized primary R5 isolates more effectively than X4 isolates, both autologous and heterologous. Child 2 raised a weak X4-specific Nab response that decreased sharply as disease progressed. Rate of evolution, nucleotide and amino acid diversity, and positive selection, were significantly higher in the envelope of child 1 compared to child 2. Rates of R5-to-X4 tropism switch, of V1 and V3 sequence diversification, and of convergence of V3 to a β-hairpin structure were related with rate of escape from the neutralizing antibodies. CONCLUSION: Our data suggests that the molecular and phenotypic evolution of the human immunodeficiency virus type 2 envelope are related with the dynamics of the neutralizing antibody response providing further support for a model in which Nabs play an important role in HIV-2 pathogenesis. BioMed Central 2013-10-24 /pmc/articles/PMC4016255/ /pubmed/24156513 http://dx.doi.org/10.1186/1742-4690-10-110 Text en Copyright © 2013 Rocha et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Rocha, Cheila Calado, Rita Borrego, Pedro Marcelino, José Maria Bártolo, Inês Rosado, Lino Cavaco-Silva, Patrícia Gomes, Perpétua Família, Carlos Quintas, Alexandre Skar, Helena Leitner, Thomas Barroso, Helena Taveira, Nuno Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response |
title | Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response |
title_full | Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response |
title_fullStr | Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response |
title_full_unstemmed | Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response |
title_short | Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response |
title_sort | evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016255/ https://www.ncbi.nlm.nih.gov/pubmed/24156513 http://dx.doi.org/10.1186/1742-4690-10-110 |
work_keys_str_mv | AT rochacheila evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse AT caladorita evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse AT borregopedro evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse AT marcelinojosemaria evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse AT bartoloines evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse AT rosadolino evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse AT cavacosilvapatricia evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse AT gomesperpetua evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse AT familiacarlos evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse AT quintasalexandre evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse AT skarhelena evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse AT leitnerthomas evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse AT barrosohelena evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse AT taveiranuno evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse |